Older adults who use statins are not at greater risk of incident dementia, mild cognitive impairment or declines in individual cognition domains than their peers who are not taking the drugs, Australian researchers confirm.

The investigators examined data on nearly 19,000 adults aged 65 years and older who participated in the ASPREE (Aspirin in Reducing Events in the Elderly) trial and had no history of cardiovascular events, dementia or major physical disability.